社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
zetheraine
IP属地:未知
+关注
帖子 · 17
帖子 · 17
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
zetheraine
zetheraine
·
2021-12-23
Buy or not?
Biogen shares fell 1.2% in early trading<blockquote>百健股价早盘下跌 1.2%</blockquote>
Biogen shares fell 1.2% in early trading.A Japanese health ministry panel said on Wednesday that inc
Biogen shares fell 1.2% in early trading<blockquote>百健股价早盘下跌 1.2%</blockquote>
看
2,656
回复
评论
点赞
1
编组 21备份 2
分享
举报
zetheraine
zetheraine
·
2021-12-23
Is this the chance for 1.5k price target?
非常抱歉,此主贴已删除
看
2,854
回复
1
点赞
2
编组 21备份 2
分享
举报
zetheraine
zetheraine
·
2021-12-23
$Microsoft(MSFT)$
should I sell it now?
看
3,791
回复
4
点赞
4
编组 21备份 2
分享
举报
zetheraine
zetheraine
·
2021-12-22
$Tesla Motors(TSLA)$
$1500 in 2022?
看
3,119
回复
1
点赞
3
编组 21备份 2
分享
举报
zetheraine
zetheraine
·
2021-12-22
$American Virtual Cloud Technologies, Inc.(AVCT)$
Fell again? :(
看
2,808
回复
评论
点赞
2
编组 21备份 2
分享
举报
zetheraine
zetheraine
·
2021-12-18
Ok
非常抱歉,此主贴已删除
看
4,234
回复
1
点赞
2
编组 21备份 2
分享
举报
zetheraine
zetheraine
·
2021-12-17
$American Virtual Cloud Technologies, Inc.(AVCT)$
up to 1.80?
看
3,296
回复
评论
点赞
1
编组 21备份 2
分享
举报
zetheraine
zetheraine
·
2021-12-15
$Galera Therapeutics, Inc.(GRTX)$
Close at 3.30 tonight? Possible?
看
3,049
回复
评论
点赞
2
编组 21备份 2
分享
举报
zetheraine
zetheraine
·
2021-12-15
$Galera Therapeutics, Inc.(GRTX)$
up to 3.05?
看
3,703
回复
评论
点赞
1
编组 21备份 2
分享
举报
zetheraine
zetheraine
·
2021-12-14
$Nuverra Environmental Solutions, Inc.(NES)$
omgness it dropped after I buy 😔
看
2,904
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4098271159372920","uuid":"4098271159372920","gmtCreate":1635169102872,"gmtModify":1635755740902,"name":"zetheraine","pinyin":"zetheraine","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/8837a06e7c83687d978d4c2954d0e13a","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":4,"headSize":5,"tweetSize":17,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖(非转发)","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.04.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.72%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"60.69%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":691207186,"gmtCreate":1640190155529,"gmtModify":1640190155636,"author":{"id":"4098271159372920","authorId":"4098271159372920","name":"zetheraine","avatar":"https://static.tigerbbs.com/8837a06e7c83687d978d4c2954d0e13a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098271159372920","authorIdStr":"4098271159372920"},"themes":[],"title":"","htmlText":"Buy or not?","listText":"Buy or not?","text":"Buy or not?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691207186","repostId":"1104039472","repostType":4,"repost":{"id":"1104039472","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640184691,"share":"https://www.laohunote.com/m/news/1104039472?lang=zh_CN&edition=full","pubTime":"2021-12-22 22:51","market":"us","language":"en","title":"Biogen shares fell 1.2% in early trading<blockquote>百健股价早盘下跌 1.2%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1104039472","media":"Tiger Newspress","summary":"Biogen shares fell 1.2% in early trading.A Japanese health ministry panel said on Wednesday that inc","content":"<p>Biogen shares fell 1.2% in early trading.<img src=\"https://static.tigerbbs.com/22ab29bf4110d582a44955c778f3cf48\" tg-width=\"713\" tg-height=\"596\" width=\"100%\" height=\"auto\">A Japanese health ministry panel said on Wednesday that inconsistent trial results made it difficult to determine the efficacy of an Alzheimer's treatment developed by Eisai Co and Biogen Inc.</p><p><blockquote>百健股价早盘下跌 1.2%。日本厚生劳动省的一个小组周三表示,不一致的试验结果使得很难确定卫材公司和百健公司开发的阿尔茨海默氏症治疗药物的疗效。</blockquote></p><p> Tokyo-based Eisai and its United States partner filed for Japanese regulatory approval just over a year ago for the drug Aduhelm, which was approved in the United States in June.</p><p><blockquote>总部位于东京的卫材及其美国合作伙伴一年多前就向日本监管部门申请了药物 Aduhelm 的批准,该药物于 6 月在美国获得批准。</blockquote></p><p> In a statement the panel cited inconsistent results from global Phase III trials and a lack of clinical significance in the drug's ability to reduce plaques in the brain. The panel said it would take another look if further data is submitted.</p><p><blockquote>在一份声明中,该小组引用了全球 III 期试验的不一致结果,以及该药物减少大脑斑块的能力缺乏临床意义。该小组表示,如果提交更多数据,将重新审查。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen shares fell 1.2% in early trading<blockquote>百健股价早盘下跌 1.2%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen shares fell 1.2% in early trading<blockquote>百健股价早盘下跌 1.2%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-22 22:51</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Biogen shares fell 1.2% in early trading.<img src=\"https://static.tigerbbs.com/22ab29bf4110d582a44955c778f3cf48\" tg-width=\"713\" tg-height=\"596\" width=\"100%\" height=\"auto\">A Japanese health ministry panel said on Wednesday that inconsistent trial results made it difficult to determine the efficacy of an Alzheimer's treatment developed by Eisai Co and Biogen Inc.</p><p><blockquote>百健股价早盘下跌 1.2%。日本厚生劳动省的一个小组周三表示,不一致的试验结果使得很难确定卫材公司和百健公司开发的阿尔茨海默氏症治疗药物的疗效。</blockquote></p><p> Tokyo-based Eisai and its United States partner filed for Japanese regulatory approval just over a year ago for the drug Aduhelm, which was approved in the United States in June.</p><p><blockquote>总部位于东京的卫材及其美国合作伙伴一年多前就向日本监管部门申请了药物 Aduhelm 的批准,该药物于 6 月在美国获得批准。</blockquote></p><p> In a statement the panel cited inconsistent results from global Phase III trials and a lack of clinical significance in the drug's ability to reduce plaques in the brain. The panel said it would take another look if further data is submitted.</p><p><blockquote>在一份声明中,该小组引用了全球 III 期试验的不一致结果,以及该药物减少大脑斑块的能力缺乏临床意义。该小组表示,如果提交更多数据,将重新审查。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104039472","content_text":"Biogen shares fell 1.2% in early trading.A Japanese health ministry panel said on Wednesday that inconsistent trial results made it difficult to determine the efficacy of an Alzheimer's treatment developed by Eisai Co and Biogen Inc.\nTokyo-based Eisai and its United States partner filed for Japanese regulatory approval just over a year ago for the drug Aduhelm, which was approved in the United States in June.\nIn a statement the panel cited inconsistent results from global Phase III trials and a lack of clinical significance in the drug's ability to reduce plaques in the brain. The panel said it would take another look if further data is submitted.","news_type":1,"symbols_score_info":{"BIIB":0.9}},"isVote":1,"tweetType":1,"viewCount":2656,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691207005,"gmtCreate":1640190124033,"gmtModify":1640190124325,"author":{"id":"4098271159372920","authorId":"4098271159372920","name":"zetheraine","avatar":"https://static.tigerbbs.com/8837a06e7c83687d978d4c2954d0e13a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098271159372920","authorIdStr":"4098271159372920"},"themes":[],"title":"","htmlText":"Is this the chance for 1.5k price target?","listText":"Is this the chance for 1.5k price target?","text":"Is this the chance for 1.5k price target?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691207005","repostId":"2193192720","repostType":4,"isVote":1,"tweetType":1,"viewCount":2854,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691204291,"gmtCreate":1640190086815,"gmtModify":1640190086924,"author":{"id":"4098271159372920","authorId":"4098271159372920","name":"zetheraine","avatar":"https://static.tigerbbs.com/8837a06e7c83687d978d4c2954d0e13a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098271159372920","authorIdStr":"4098271159372920"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/MSFT\">$Microsoft(MSFT)$</a>should I sell it now?","listText":"<a href=\"https://laohu8.com/S/MSFT\">$Microsoft(MSFT)$</a>should I sell it now?","text":"$Microsoft(MSFT)$should I sell it now?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/691204291","isVote":1,"tweetType":1,"viewCount":3791,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691648128,"gmtCreate":1640188002072,"gmtModify":1640188002186,"author":{"id":"4098271159372920","authorId":"4098271159372920","name":"zetheraine","avatar":"https://static.tigerbbs.com/8837a06e7c83687d978d4c2954d0e13a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098271159372920","authorIdStr":"4098271159372920"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>$1500 in 2022?","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>$1500 in 2022?","text":"$Tesla Motors(TSLA)$$1500 in 2022?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691648128","isVote":1,"tweetType":1,"viewCount":3119,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691907269,"gmtCreate":1640107492499,"gmtModify":1640107492574,"author":{"id":"4098271159372920","authorId":"4098271159372920","name":"zetheraine","avatar":"https://static.tigerbbs.com/8837a06e7c83687d978d4c2954d0e13a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098271159372920","authorIdStr":"4098271159372920"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/AVCT\">$American Virtual Cloud Technologies, Inc.(AVCT)$</a>Fell again? :(","listText":"<a href=\"https://laohu8.com/S/AVCT\">$American Virtual Cloud Technologies, Inc.(AVCT)$</a>Fell again? :(","text":"$American Virtual Cloud Technologies, Inc.(AVCT)$Fell again? :(","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691907269","isVote":1,"tweetType":1,"viewCount":2808,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699801629,"gmtCreate":1639763467860,"gmtModify":1639763467941,"author":{"id":"4098271159372920","authorId":"4098271159372920","name":"zetheraine","avatar":"https://static.tigerbbs.com/8837a06e7c83687d978d4c2954d0e13a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098271159372920","authorIdStr":"4098271159372920"},"themes":[],"title":"","htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699801629","repostId":"2192597562","repostType":4,"isVote":1,"tweetType":1,"viewCount":4234,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690247639,"gmtCreate":1639673367609,"gmtModify":1639673367685,"author":{"id":"4098271159372920","authorId":"4098271159372920","name":"zetheraine","avatar":"https://static.tigerbbs.com/8837a06e7c83687d978d4c2954d0e13a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098271159372920","authorIdStr":"4098271159372920"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/AVCT\">$American Virtual Cloud Technologies, Inc.(AVCT)$</a>up to 1.80?","listText":"<a href=\"https://laohu8.com/S/AVCT\">$American Virtual Cloud Technologies, Inc.(AVCT)$</a>up to 1.80?","text":"$American Virtual Cloud Technologies, Inc.(AVCT)$up to 1.80?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690247639","isVote":1,"tweetType":1,"viewCount":3296,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607704818,"gmtCreate":1639583762197,"gmtModify":1639583785108,"author":{"id":"4098271159372920","authorId":"4098271159372920","name":"zetheraine","avatar":"https://static.tigerbbs.com/8837a06e7c83687d978d4c2954d0e13a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098271159372920","authorIdStr":"4098271159372920"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/GRTX\">$Galera Therapeutics, Inc.(GRTX)$</a>Close at 3.30 tonight? Possible? ","listText":"<a href=\"https://laohu8.com/S/GRTX\">$Galera Therapeutics, Inc.(GRTX)$</a>Close at 3.30 tonight? Possible? ","text":"$Galera Therapeutics, Inc.(GRTX)$Close at 3.30 tonight? Possible?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607704818","isVote":1,"tweetType":1,"viewCount":3049,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607129064,"gmtCreate":1639500685977,"gmtModify":1639500686076,"author":{"id":"4098271159372920","authorId":"4098271159372920","name":"zetheraine","avatar":"https://static.tigerbbs.com/8837a06e7c83687d978d4c2954d0e13a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098271159372920","authorIdStr":"4098271159372920"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/GRTX\">$Galera Therapeutics, Inc.(GRTX)$</a>up to 3.05? ","listText":"<a href=\"https://laohu8.com/S/GRTX\">$Galera Therapeutics, Inc.(GRTX)$</a>up to 3.05? ","text":"$Galera Therapeutics, Inc.(GRTX)$up to 3.05?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607129064","isVote":1,"tweetType":1,"viewCount":3703,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604582766,"gmtCreate":1639412042863,"gmtModify":1639412764935,"author":{"id":"4098271159372920","authorId":"4098271159372920","name":"zetheraine","avatar":"https://static.tigerbbs.com/8837a06e7c83687d978d4c2954d0e13a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098271159372920","authorIdStr":"4098271159372920"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/NES\">$Nuverra Environmental Solutions, Inc.(NES)$</a>omgness it dropped after I buy 😔","listText":"<a href=\"https://laohu8.com/S/NES\">$Nuverra Environmental Solutions, Inc.(NES)$</a>omgness it dropped after I buy 😔","text":"$Nuverra Environmental Solutions, Inc.(NES)$omgness it dropped after I buy 😔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604582766","isVote":1,"tweetType":1,"viewCount":2904,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}